HELICOBACTER PYLORI DIAGNOSTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Helicobacter Pylori Diagnostics - Overview Global Helicobacter Pylori Diagnostics Market, by Diagnosis Type (Invasive (Immunoassay, Rapid Urease Test, and Histology) and Non-invasive (Stool Antigen Assay, Serology Tests, and Urea Breath Test)), by End User (Hospitals, Clinics, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) estimated to be valued at US$ 437.3 million in 2017, and is estimated to exhibit a CAGR of 7.1% over the forecast period (2018-2026). Key players are focusing on gaining product approvals by regulatory bodies and product launches by market players to strengthen their position in the global helicobacter pylori diagnostics market, and this is expected to drive growth of the market over the forecast period. For instance, Diasorin S.P.A. launched fully automated solution, LIASION, for H. pylori detection, intended for markets outside the U.S. in 2016. Similarly, in 2016, Exalenz Bioscience received the U.S. Food and Drug Administration (FDA) marketing clearance for its BreathID Lab System and breath-test kits developed for H. pylori bacterium detection. Moreover, the company received approval from the U.S. FDA to market its lab system and its point-of-care device for H. pylori detection in pediatric patients. Moreover, inorganic strategies of market players are also propelling the market growth, in March 2018. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/helicobacter-pylori-diagnostics-market-1874 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Browse Market Data 27 Tables and 30 Figures spread through 167 Pages and in-depth TOC on "Helicobacter Pylori Diagnostics Market, by Test Type (Invasive (Immunoassay, Rapid Urease Test and Histology) and Non-invasive (Stool Antigen Assay, Serology Tests and Urea Breath Test)), by End User (Hospitals, Clinics, Diagnostic Laboratories and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Global Forecast to 2026� The increasing prevalence of helicobacter pylori infections in emerging economies is driving demand for helicobacter pylori diagnostic assay kits. For instance, according to the Faculty of Medicine of Chinese University of Hong Kong, 2017, Africa has highest prevalence of helicobacter pylori infections (which is around 79%). Moreover, there is increasing unmet needs of detection and treatment for helicobacter pylori infections, as the there is no direct marketing of the products by market player and products are made available by the government only. Countries with declining incidence of Helicobacter pylori infection are also engaged in complete eradication of infection. Eradication is supported by various government initiatives such as to provide diagnostics test at lower rates and increasing screening programs. For instance, in 2013, the Japan government approved national health insurance coverage for antibiotic treatment for H. pylori infection in patients with chronic gastritis and diagnosed by endoscopic method. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1874
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION • Key takeaways of the Helicobacter Pylori diagnostics Market: • The global helicobacter pylori diagnostics market is expected to exhibit a CAGR of 7.1% over the forecast period (2018-2026), attributed to rising demand for point-of-care testing devices, for early detection of the disease. • Among test type, invasive segment is expected to hold a dominant position in the market over the forecast period, owing to introduction of better diagnostic assay with high sensitivity and specificity by major market players. • Among regions, North America is expected to hold a dominant position in the market over the forecast period, attributed to increasing adoption of H. pylori eradication programs leading to high demand for H. Pylori diagnostic test products. • Key players operating in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc., among others Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1874 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved